Reaction

Mycobacterium Abscessus Infection reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 696 reports · 40 co-occurring drugs

As of the last recalculation, Mycobacterium Abscessus Infection appears in 696 FAERS reports alongside 40 co-occurring drug terms. The strongest observed disproportionality signal is AMIKACIN (PRR 381.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Amikacin	166	381.9	385.6
Moxifloxacin	55	126.7	127.2
Linezolid	88	101.0	101.3
Moxifloxacin Hydrochloride	60	96.8	97.0
Clarithromycin	77	75.3	75.5
Azithromycin	85	71.8	72.0
Azithromycin Monohydrate	86	70.3	70.4
Rifampin	29	61.9	62.1
Minocycline	22	58.2	58.4
Pyrazinamide	17	55.5	55.6
Basiliximab	21	55.0	55.1
Azithromycin Dihydrate	89	51.9	52.0
Tacrolimus Ointment 0.1%	148	44.9	44.9
Tacrolimus Extended-Release Capsules	148	44.7	44.8
Rifampicin	14	42.2	42.3
Tobramycin Solution	15	38.1	38.2
Tacrolimus	154	37.5	37.5
Tobramycin Sulfate	15	37.0	37.0
Posaconazole Delayed-Release	13	36.1	36.1
Gentamicin	15	35.0	35.1
Isoniazid	18	34.1	34.1
Voriconazole Injection	22	31.3	31.3
Gentamicin Sulfate	16	31.0	31.0
Meropenem	28	27.1	27.2
Mycophenolate Mofetil	105	27.0	27.1
Mycophenolate Mofetil Hydrochloride	105	27.0	27.0
Tobramycin	21	26.9	26.9
Elexacaftor, Tezacaftor, And Ivacaftor	11	26.8	26.8
Voriconazole	25	25.5	25.5
Valganciclovir Hydrochloride Powder,	10	24.9	24.9
Daspone	8	24.8	24.9
Dapsone Gel, 5%	8	24.8	24.8
Posaconazole	13	24.4	24.4
Dapsone	8	22.7	22.7
Cefepime	10	21.2	21.2
Cefepime Hydrochloride	11	20.7	20.7
Lumacaftor And Ivacaftor	5	17.6	17.6
Dornase Alfa	11	17.0	17.0
Botulinum Toxin Type A	7	17.0	17.0
Ivacaftor	3	11.3	11.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.